Updated Jul 16, 2026
Peetz Christopher has filed 2 SEC Form 4 filings across 1 company in the last 90 days — selling. Lifetime open-market sales: $16.04M.
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-07-08 | MIRM | Mirum Pharmaceuticals, Inc. | S — Open-market sale | 1.7K | $124.79 | $213K |
| 2026-07-08 | MIRM | Mirum Pharmaceuticals, Inc. | S — Open-market sale | 2.0K | $123.74 | $244K |
| 2026-07-08 | MIRM | Mirum Pharmaceuticals, Inc. | S — Open-market sale | 4.2K | $122.34 | $512K |
| 2026-07-08 | MIRM | Mirum Pharmaceuticals, Inc. | S — Open-market sale | 12.1K | $121.65 | $1.48M |
| 2026-07-08 | MIRM | Mirum Pharmaceuticals, Inc. | M — Option exercise | 20.0K | $2.94 | $59K |
| 2026-06-02 | MIRM | Mirum Pharmaceuticals, Inc. | S — Open-market sale | 883 | $99.66 | $88K |
| 2026-06-02 | MIRM | Mirum Pharmaceuticals, Inc. | S — Open-market sale | 1.0K | $98.20 | $100K |
| 2026-06-02 | MIRM | Mirum Pharmaceuticals, Inc. | S — Open-market sale | 2.0K | $97.56 | $192K |
| 2026-06-02 | MIRM | Mirum Pharmaceuticals, Inc. | S — Open-market sale | 6.9K | $96.15 | $666K |
| 2026-06-02 | MIRM | Mirum Pharmaceuticals, Inc. | S — Open-market sale | 16.6K | $95.34 | $1.58M |
| 2026-06-02 | MIRM | Mirum Pharmaceuticals, Inc. | S — Open-market sale | 2.6K | $94.64 | $246K |
| 2026-06-02 | MIRM | Mirum Pharmaceuticals, Inc. | M — Option exercise | 30.0K | $2.94 | $88K |
| 2026-03-17 | MIRM | Mirum Pharmaceuticals, Inc. | S — Open-market sale | 41.0K | $91.98 | $3.77M |
| 2026-03-17 | MIRM | Mirum Pharmaceuticals, Inc. | M — Option exercise | 50.0K | — | |
| 2026-03-17 | MIRM | Mirum Pharmaceuticals, Inc. | M — Option exercise | 25.0K | — | |
| 2026-02-04 | MIRM | Mirum Pharmaceuticals, Inc. | S — Open-market sale | 9.1K | $103.30 | $941K |
| 2026-01-27 | MIRM | Mirum Pharmaceuticals, Inc. | S — Open-market sale | 6.8K | $96.19 | $657K |
| 2026-01-27 | MIRM | Mirum Pharmaceuticals, Inc. | M — Option exercise | 12.5K | — | |
| 2026-01-23 | MIRM | Mirum Pharmaceuticals, Inc. | S — Open-market sale | 7.1K | $93.33 | $662K |
| 2026-01-23 | MIRM | Mirum Pharmaceuticals, Inc. | M — Option exercise | 12.8K | — |
Peetz Christopher is a corporate insider — currently tracked as Insider of Mirum Pharmaceuticals, Inc. (MIRM). InsiderAlpha tracks every SEC Form 4 filing in real time.
2 primary Form 4 filings in the last 90 days, covering 1 company.
Recorded transactions: 0 open-market purchases () and 16 open-market sales ($16.04M) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Peetz Christopher profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.